Clinical trial
Substance Misuse To Psychosis for Stimulants (SToP-S)--An Early Assertive Pharmacotherapy Intervention Study
NCT03485417 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Substance Misuse To Psychosis for Stimulants (SToP-S)--An Early Assertive Pharmacotherapy Intervention Study
- Lead sponsor
- The University of Hong Kong
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 1, 2019
- Completion date
- May 31, 2025
- Enrollment
- 165 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pharmacotherapy, schizophrenia and related disorders, stimulant abuse, stimulant dependence, stimulant use with stimulant-induced psychotic disorder (diagnosis)